Medicare Enrolled

Dr. Jayshree Dhali, M.D.

Endocrinology · Chicago, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2740 W FOSTER AVE, Chicago, IL 60625
7737699200
In practice since 2006 (20 years)
NPI: 1952350803 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dhali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dhali

Dr. Jayshree Dhali is an endocrinology specialist in Chicago, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dhali performed 859 Medicare services across 452 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dhali received a total of $13,408 from 45 pharmaceutical and/or device companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dhali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 47% volume in IL $13,408 industry payments

Medicare Practice Summary

Medicare Utilization ↗
859
Medicare services
Top 47% in IL for endocrinology
452
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
620 $96 $280
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
95 $10 $30
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
66 $29 $136
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
56 $131 $371
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $58 $203
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,408
Total received (2018-2024)
Avg $1,915/year across 7 years
Top 18% in IL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
650
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,500 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$908 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,804
2023
$1,575
2022
$2,015
2021
$606
2020
$742
2019
$2,944
2018
$2,721

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$427
Novo Nordisk Inc
$404
Corcept Therapeutics
$352
Amgen Inc.
$341
Lilly USA, LLC
$205
Bayer Healthcare Pharmaceuticals Inc.
$191
Amneal Pharmaceuticals LLC
$149
Radius Health, Inc.
$131
SANOFI-AVENTIS U.S. LLC
$124
ABBVIE INC.
$80
Abbott Laboratories
$71
Ascensia Diabetes Care Us Inc.
$66
Medtronic, Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Amphastar Pharmaceuticals, Inc.
$44
Xeris Pharmaceuticals, Inc.
$39
BETA BIONICS, INC.
$25
AstraZeneca Pharmaceuticals LP
$23
Ascendis Pharma Inc
$18
Top 3 companies account for 42.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,925
SANOFI-AVENTIS U.S. LLC
$1,537
Dexcom, Inc.
$965
Boehringer Ingelheim Pharmaceuticals, Inc.
$915
Lilly USA, LLC
$857
Amgen Inc.
$604
AstraZeneca Pharmaceuticals LP
$539
Horizon Therapeutics plc
$537
Amneal Pharmaceuticals LLC
$509
Corcept Therapeutics
$366
Merck Sharp & Dohme Corporation
$349
Becton, Dickinson and Company
$345
Janssen Pharmaceuticals, Inc
$330
AbbVie, Inc.
$323
Bayer Healthcare Pharmaceuticals Inc.
$297
Shire North American Group Inc
$292
Xeris Pharmaceuticals, Inc.
$285
ABBVIE INC.
$269
Radius Health, Inc.
$195
Mannkind Corporation
$187
Insulet Corporation
$176
Abbott Laboratories
$175
Bayer HealthCare Pharmaceuticals Inc.
$170
MannKind Corporation
$163
Medtronic, Inc.
$153
AbbVie Inc.
$145
Amarin Pharma Inc.
$126
Gemini Laboratories, LLC
$78
LifeScan, Inc.
$73
Ascensia Diabetes Care Us Inc.
$66
Amryt Pharma Holdings Ltd
$63
Medtronic MiniMed, Inc.
$62
Ultragenyx Pharmaceutical Inc.
$59
IBSA Pharma Inc.
$53
Tandem Diabetes Care, Inc.
$52
Amphastar Pharmaceuticals, Inc.
$44
BETA BIONICS, INC.
$25
Ascendis Pharma Inc
$18
Relypsa, Inc.
$14
Companion Medical, Inc.
$13
Valeritas, Inc.
$13
VBI Vaccines (Delaware) Inc.
$12
Intuity Medical Inc
$11
Takeda Pharmaceuticals U.S.A., Inc.
$11
CeQur Corporation
$8
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD NANO · BD Nano · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN U · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LINZESS · LYUMJEV · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NO PRODUCT DISCUSSED · NovoLog · Omnipod · OneTouch · Ozempic · Pogo Automatic Blood Glucose Monitoring System · PreHevbrio · Prolia · RECORLEV · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLUJAN · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veltassa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Chicago?
Compare endocrinologists in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
214
Per 100K population
4.1
County median income
$81,797
Nearest hospital
SWEDISH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dhali is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dhali experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dhali performed 620 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dhali receive payments from pharmaceutical companies?
Yes. Dr. Dhali received a total of $13,408 from 45 companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhali's costs compare to other endocrinologists in Chicago?
Dr. Dhali's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →